Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Emeritus Professor Irene Roberts holds the 2022 Ham-Wasserman Lecture Award from the American Society of Hematology.

Emeritus Professor Irene Roberts, leader of the Fetal and Neonatal Haematology Group at the MRC Molecular Haematology Unit delivered the prestigious 2022 Ham-Wasserman Lecture at the 64th ASH Annual Meeting and Exposition, held in New Orleans Louisiana in December 2022. The Ham-Wasserman lecture honours two past ASH presidents, Dr Thomas Hale Ham and Dr Louis R Wasserman.

Professor Roberts delivered the lecture entitled: ‘Why Is the Risk of Developing Leukemia So High in Children with Down Syndrome and What Can We Do About It?’

The American Society of Hematology Annual Meeting is a high-profile event in the field of hematology, with past meetings attracting more than 30,000 attendees.

The lecture abstract is now available on the ASH website: 2022 Ham-Wasserman Lecture

Recent stories

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.